Optimum Perspectives
Total duration:
5 h 43 min
Anglonordic Life Science Conference strikes optimistic note for ‘24
Optimum Perspectives
09:12
The challenges of recruitment for clinical trials
Optimum Perspectives
24:16
Lytix Biopharma – Innovations in Killing Cancer
Optimum Perspectives
17:07
Tackling Rare Diseases in 2024
Optimum Perspectives
38:09
International Day of Women & Girls in Science: Breaking barriers and channeling your inner cavewoman
Optimum Perspectives
27:40
Optimum's European Life Sciences Investor Survey 2024
Optimum Perspectives
17:46
Vicore Pharma: Restoring lung function for IPF patients
Optimum Perspectives
11:29
Optimum's Christmas charity special featuring Ariana Smiles
Optimum Perspectives
16:28
4SC: Creating a new treatment paradigm for CTCL
Optimum Perspectives
17:30
Episode 10: Optimum's 15th Annual Healthcare Investor Conference Special
Optimum Perspectives
08:45
Ask Eva: biopharma's market trends in 2023
Optimum Perspectives
14:09
Alchemab: The UK biotech that is revolutionising drug discovery
Optimum Perspectives
17:53
Poolbeg Pharma: Using AI to prepare for the next pandemic
Optimum Perspectives
16:27
Verona Pharma: Preparing a potentially novel COPD medicine for market
Optimum Perspectives
17:32
Søren Møller of Novo Holdings Seed Investments – Helping small biotechs weather the storm
Optimum Perspectives
21:28
Renée Aguiar-Lucander, CEO of Calliditas Therapeutics: Blazing a trail in rare diseases
Optimum Perspectives
23:02
An interview with Dan Mahony, UK Government Life Sciences Envoy, by Optimum’s Eva Haas
Optimum Perspectives
22:38
Versameb: Revolutionizing SUI therapy with mRNA technology 
Optimum Perspectives
12:55
CellCentric's new oral cancer therapy inobrodib
Optimum Perspectives
09:29